Alejandro Francisco‐Cruz

2.3k total citations
35 papers, 517 citations indexed

About

Alejandro Francisco‐Cruz is a scholar working on Oncology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Alejandro Francisco‐Cruz has authored 35 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Epidemiology and 7 papers in Infectious Diseases. Recurrent topics in Alejandro Francisco‐Cruz's work include Tuberculosis Research and Epidemiology (7 papers), Global Cancer Incidence and Screening (6 papers) and Renal cell carcinoma treatment (4 papers). Alejandro Francisco‐Cruz is often cited by papers focused on Tuberculosis Research and Epidemiology (7 papers), Global Cancer Incidence and Screening (6 papers) and Renal cell carcinoma treatment (4 papers). Alejandro Francisco‐Cruz collaborates with scholars based in United States, Mexico and Spain. Alejandro Francisco‐Cruz's co-authors include Ignacio I. Wistuba, Edwin R. Parra, Rogélio Hernández‐Pando, Dulce Mata‐Espinosa, Brenda Marquina‐Castillo, Jorge Barrios‐Payán, Miguel Aguilar‐Santelises, Michael T. Tetzlaff, Valentine Nfonsam and Zhou Xing and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Alejandro Francisco‐Cruz

30 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alejandro Francisco‐Cruz United States 13 156 152 141 103 93 35 517
Seiko Kato Japan 14 127 0.8× 142 0.9× 99 0.7× 46 0.4× 86 0.9× 80 691
Daniel D. Miller United States 8 164 1.1× 81 0.5× 108 0.8× 144 1.4× 188 2.0× 46 568
Brittany Holmes United States 14 126 0.8× 134 0.9× 109 0.8× 51 0.5× 108 1.2× 24 594
Sara Martina Parigi Italy 11 125 0.8× 198 1.3× 255 1.8× 49 0.5× 65 0.7× 19 602
Anna Löfgren‐Burström Sweden 12 232 1.5× 101 0.7× 290 2.1× 50 0.5× 70 0.8× 18 563
Carmen Garrigós Spain 11 202 1.3× 111 0.7× 112 0.8× 141 1.4× 92 1.0× 19 508
Laleh Sharifi Iran 14 96 0.6× 305 2.0× 112 0.8× 45 0.4× 57 0.6× 57 598
Étienne Daguindau France 17 197 1.3× 223 1.5× 137 1.0× 221 2.1× 215 2.3× 54 815
Ippei Sakamaki Japan 12 170 1.1× 293 1.9× 171 1.2× 261 2.5× 79 0.8× 48 746
Mathieu Garand United States 13 46 0.3× 195 1.3× 147 1.0× 97 0.9× 182 2.0× 32 585

Countries citing papers authored by Alejandro Francisco‐Cruz

Since Specialization
Citations

This map shows the geographic impact of Alejandro Francisco‐Cruz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Francisco‐Cruz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Francisco‐Cruz more than expected).

Fields of papers citing papers by Alejandro Francisco‐Cruz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Francisco‐Cruz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Francisco‐Cruz. The network helps show where Alejandro Francisco‐Cruz may publish in the future.

Co-authorship network of co-authors of Alejandro Francisco‐Cruz

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Francisco‐Cruz. A scholar is included among the top collaborators of Alejandro Francisco‐Cruz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Francisco‐Cruz. Alejandro Francisco‐Cruz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wightman, Patrick, Alejandro Francisco‐Cruz, Eric Kauffman, et al.. (2024). Differential effects of obesity on perioperative outcomes in renal cell carcinoma patients based on race and ethnicity and neighborhood-level socioeconomic status. Translational Andrology and Urology. 13(4). 548–559.
2.
Rodríguez‐Remírez, María, Inés López, María Collantes, et al.. (2023). A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer. Frontiers in Immunology. 14. 1272570–1272570. 1 indexed citations
3.
Gachupin, Francine C., Benjamin R. Lee, Juan Chipollini, et al.. (2022). Renal Cell Carcinoma Surgical Treatment Disparities in American Indian/Alaska Natives and Hispanic Americans in Arizona. International Journal of Environmental Research and Public Health. 19(3). 1185–1185. 7 indexed citations
4.
Francisco‐Cruz, Alejandro, Faith Dickerson, Francine C. Gachupin, et al.. (2022). Impacts of Neighborhood Characteristics and Surgical Treatment Disparities on Overall Mortality in Stage I Renal Cell Carcinoma Patients. International Journal of Environmental Research and Public Health. 19(4). 2050–2050. 5 indexed citations
5.
Francisco‐Cruz, Alejandro, et al.. (2021). Racial and Ethnic Disparities in Preoperative Surgical Wait Time and Renal Cell Carcinoma Tumor Characteristics. Healthcare. 9(9). 1183–1183. 2 indexed citations
6.
Silva‐García, Raúl, Brenda Marquina‐Castillo, Juan Carlos León‐Contreras, et al.. (2021). Monocyte Locomotion Inhibitory Factor confers neuroprotection and prevents the development of murine cerebral malaria. International Immunopharmacology. 97. 107674–107674. 4 indexed citations
7.
Hillyer, Grace Clarke, Karen M. Schmitt, Andria Reyes, et al.. (2020). Community education to enhance the more equitable use of precision medicine in Northern Manhattan. Journal of Genetic Counseling. 29(2). 247–258. 6 indexed citations
8.
Francisco‐Cruz, Alejandro, et al.. (2020). Linear Growth in Pediatric Kidney Transplant Population. Frontiers in Pediatrics. 8. 569616–569616. 6 indexed citations
9.
Wistuba, Ignacio I., Edwin R. Parra, & Alejandro Francisco‐Cruz. (2019). MS17.04 Multiplex Immunohistochemistry. Journal of Thoracic Oncology. 14(10). S191–S191.
10.
Francisco‐Cruz, Alejandro, Edwin R. Parra, Michael T. Tetzlaff, & Ignacio I. Wistuba. (2019). Multiplex Immunofluorescence Assays. Methods in molecular biology. 2055. 467–495. 42 indexed citations
11.
Hanna, Kamil, Muhammad Zeeshan, Mohammad Hamidi, et al.. (2019). Colon cancer in the young: contributing factors and short-term surgical outcomes. International Journal of Colorectal Disease. 34(11). 1879–1885. 15 indexed citations
12.
Chen, Debbie, Chiu‐Hsieh Hsu, Viraj Pandit, et al.. (2019). Racial disparities in the incidence of colon cancer in patients with inflammatory bowel disease. Journal of Gastrointestinal Oncology. 10(2). 254–258. 4 indexed citations
13.
Nfonsam, Valentine, et al.. (2018). COMP Gene Coexpresses With EMT Genes and Is Associated With Poor Survival in Colon Cancer Patients. Journal of Surgical Research. 233. 297–303. 26 indexed citations
14.
Francisco‐Cruz, Alejandro, et al.. (2018). Racial and gender disparities in the incidence of anal cancer: analysis of the Nationwide Inpatient Sample (NIS). Journal of Gastrointestinal Oncology. 10(1). 37–41. 20 indexed citations
15.
Francisco‐Cruz, Alejandro, Edwin R. Parra, Mei Jiang, et al.. (2018). OA03.05 Characterization of the Immunologic Intra-Tumor Heterogeneity in Early Stages of Non-Small Cell Lung Cancer by Multiplex Immunofluorescence. Journal of Thoracic Oncology. 13(10). S325–S326. 2 indexed citations
16.
Francisco‐Cruz, Alejandro, Dulce Mata‐Espinosa, Brenda Marquina‐Castillo, et al.. (2016). Efficacy of gene-therapy based on adenovirus encoding granulocyte-macrophage colony-stimulating factor in drug-sensitive and drug-resistant experimental pulmonary tuberculosis. Tuberculosis. 100. 5–14. 13 indexed citations
17.
Francisco‐Cruz, Alejandro, Dulce Mata‐Espinosa, Jorge Barrios‐Payán, et al.. (2016). Gene therapy based in antimicrobial peptides and proinflammatory cytokine prevents reactivation of experimental latent tuberculosis. Pathogens and Disease. 74(7). ftw075–ftw075. 18 indexed citations
18.
Bini, Estela Isabel, et al.. (2014). The Influence of Sex Steroid Hormones in the Immunopathology of Experimental Pulmonary Tuberculosis. PLoS ONE. 9(4). e93831–e93831. 71 indexed citations
19.
Francisco‐Cruz, Alejandro, Miguel Aguilar‐Santelises, Dulce Mata‐Espinosa, et al.. (2013). Granulocyte–macrophage colony-stimulating factor: not just another haematopoietic growth factor. Medical Oncology. 31(1). 774–774. 102 indexed citations
20.
Montoro, Ernesto, et al.. (2013). Immunogenicity and protection conferred by Mycobacterium habana in a murine model of pulmonary tuberculosis. Tuberculosis. 94(1). 65–72. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seiko Kato Breakdown of academic impact, for papers by Daniel D. Miller Breakdown of academic impact, for papers by Brittany Holmes Breakdown of academic impact, for papers by Sara Martina Parigi Breakdown of academic impact, for papers by Anna Löfgren‐Burström Breakdown of academic impact, for papers by Carmen Garrigós Breakdown of academic impact, for papers by Laleh Sharifi Breakdown of academic impact, for papers by Étienne Daguindau Breakdown of academic impact, for papers by Ippei Sakamaki Breakdown of academic impact, for papers by Mathieu Garand
Rankless by CCL
2026